Recent changes in the healthcare system have put a greater focus on the development and availability of generic drugs. The pharmaceutical industry has responded by exploring alternative delivery methods, creating new test designs and, most notably, developing the first American biosimilar. These advances have been met with acclaim, but they do bring new challenges. Regulatory ambiguity in testing procedures delay generic developers, and legal action from originator drug companies restricts those focusing on biosimilars. This summit will further explore the scientific necessity of this subject, while guiding experts through their collective difficulties.
2nd Bioequivalence Summit
5 - 6 October 2015, Boston, United States
Introduction
Venue
Hilton Boston Back Bay
Hilton Boston Back Bay, 40 Dalton Street, Boston, 02115, United States
Organised by
ExL Pharma
Contact information
Related events
5th SCI-欧美AV Symposium on Anti-Infectives Drug Discovery
1 June 2026 09:15 - 2 June 2026 18:00, London, United Kingdom
The 59th Annual International Meeting of the ESR Spectroscopy Group of the 欧美AV
13 April 2026 15:00 - 16 April 2026 23:00, Colchester, United Kingdom
India Pharma Expo 2026
23 April 2026 09:00 - 25 April 2026 18:00, Hyderabad, India
Service and maintenance of molecular/microbiology laboratory equipment
6 April 2026 09:00 - 10 April 2026 16:00, Nairobi, Kenya
Search
Advertisement
Spotlight
Explore
Membership
